Beyond panopticism: On the ramifications of surveillance in a contemporary professional setting

This paper provides fieldwork evidence, which solidifies an emerging view in literature, regarding the limitations of the panoptical metaphor in informing meaningfully and productively the analysis of contemporary surveillance and control. Our thesis is that the panopticon metaphor, which conceives of the organization as a bounded enclosure made up of divisible, observable and calculable spaces, is becoming less and less relevant in the age of contemporary surveillance technologies. Through a longitudinal socio-ethnographic study of the ramifications of surveillance ensuing from the implementation of a computerized knowledge management system (KMS) in a Parisian tax/law firm, our analysis points to the proliferation of lateral networks of surveillance having developed in the aftermath of implementation. In this complex and unstable constellation of rhizomatical controls, peers are involved in scrutinizing the validity of one another’s work, irrespective of the office’s hierarchies and official lines of specialization. As a result, games of visibility (exhibitionism), observation (voyeurism) and secrecy (hiding one’s work from the KMS) abound in the office. One of our main conclusions is to emphasize the pertinence of apprehending control and surveillance from angles that take into account the ambiguities, complexities and unpredictability of human institutions, especially in digitalized environments.     

Applying Ethics to the Tourism Industry

The world's largest industry has received little ethical attention, yet it raises questions of consumer fairness, marketing and environmental and cultural integrity. The author has recently gained an MSc in Tourism Studies from the University of Surrey, and is currently working as an independent consultant in the tourism and leisure sector.     

Migrants' Home Town Associations and Local Development in Mali

We explore the impact of migrants' Home Town Associations (HTAs) on the provision of public goods in Mali. We combine an original dataset on all the HTAs created by Malian migrants in France from 1981 with census data on public goods in all Malian villages since 1976, and we run double‐difference estimations to compare villages with and without an HTA, before and after the creation of the HTAs. We find robust evidence that the provision of schools, health centers, and, to a lesser extent, water amenities has increased significantly faster in villages targeted by an HTA between 1987 and 2009 than in control villages.     

Some Parallels Between Currency and Banking Crises

There is a sizeable literature on the causes of speculative attacks on fixed exchange rates and a large literature on the determinants of bank runs. Surprisingly, these two literatures rarely overlap, even though both types of crises involve attacks on asset price-fixing schemes. This paper draws a number of parallels between the work on currency crises and the work on banking crises and examines some of the new insights that are coming out of a more integrated approach in the aftermath of the Asian financial crises.     

Evaluating drug cost per responder and number needed to treat associated with lixisenatide on top of glargine when compared to rapid-acting insulin intensification regimens on top of glargine,in patients with type 2 diabetes in the UK,Italy, and Spain

Objectives: This study investigated the cost per responder and number needed to treat (NNT) in type 2 diabetes mellitus (T2DM) patients for lixisenatide compared to insulin intensification regimens using composite endpoints in the UK, Italy, and Spain.

Methods: Efficacy and safety outcomes were obtained from GetGoal Duo-2, a 26-week phase 3 trial comparing lixisenatide vs insulin glulisine (IG) once daily (QD) and three times daily (TID). Response at week 26 was extrapolated to 52 weeks, assuming a maintained treatment effect, based on long-term evidence in other T2DM populations. Responders were defined using composite end-points, based on an HbA1c threshold and/or no weight gain and/or no hypoglycemia. The HbA1c threshold was varied in sensitivity analyses. Annual treatment costs were estimated in euros (1 GBP?=?1.26 EUR), including drug acquisition and resource use costs. Cost per responder was computed by dividing annual treatment costs per patient by the proportion of responders.

Results: Lixisenatide was associated with the lowest cost per responder for all composite end-points that included a weight-related component. For the main composite end-point of HbA1c ≤7.5% AND no weight gain AND no symptomatic hypoglycemia, cost per responder results were: UK: 6,867€, 8,746€, and 12,410€; Italy: 7,057€, 9,160€, and 12,844€; Spain: 8,370€, 11,365€, and 17,038€, for lixisenatide, IG QD, and TID, respectively. The NNT analysis showed that, for every 6.85 and 5.86 patients treated with lixisenatide, there was approximately one additional responder compared to IG QD and TID, respectively.

Limitations: A limitation of the clinical inputs is the lack of 52-week trial data from GetGoal Duo-2, which led to the assumption of a maintained treatment effect from week 26 to 52.

Conclusions: This analysis suggests lixisenatide is an efficient economic resource allocation in the UK, Italy, and Spain.